TuHURA Biosciences, Inc.
HURA· Nasdaq
HURATuHURA Biosciences, Inc.
Source filing unavailable
| Metric | Q2 2014 | Q2 2012 |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | $865.98K | -$1.14M |
| EPS Diluted | $0.03 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
